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ABSTRACT
Ocular complications are common in patients with end-stage renal disease treated with
hemodialysis. Disability due to visual impairment in these patients represents a global public health problem. The study aimed to estimate the hemodialysis effect on intraocular
pressure (IOP) fluctuation and related factors. A cross-sectional study of 60 patients with
hemodialysis (120 eyes) from the hemodialysis unit at a major tertiary teaching hospital in
Palestine. Clinical tests were carried out using the Goldman application tonometry and the
volk 90d non-contact slit lamp lens. Participant's mean age was 55.5±12.6 years. Thirtytwo of them were males (53.3%), and 22 (36.7%) were diabetic. IOP changed significantly
after hemodialysis compared to pre hemodialysis level; (14.28±2.68mmHg before versus
12.39±2.24 after hemodialysis) (P<0.001). This change was more significant among females (P<0.001) and patients with diabetes (P=0.001) and correlated significantly with
baseline systolic blood pressure (P=0.002), serum sodium (P<0.001), chloride (P=0.034),
BUN (P=0.01), and osmolarity (P<0.001). In conclusion, hemodialysis treatment affects
IOP and several other laboratory parameters significantly. It likely causes underestimation
of IOP and corneal morphometry changes, and these changes may be necessary when
planning corneal or lenticular surgeries in hemodialysis patients.
Keywords: Chronic kidney disease, Hemodialysis, Intraocular Pressure, Palestine.
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INTRODUCTION
Chronic kidney disease (CKD) is
prevalent worldwide, with approximately
11% to 13%. [1]. It is often progressive,
leading to irreversible loss of kidney
function known as an end-stage renal disease (ESRD). The only treatment options
for patients with ESRD are dialysis, hemodialysis or peritoneal dialysis, and
kidney transplantation [2, 3]. The preva-

lence of ESRD in Palestine reached 240.3
per million in 2010, which is comparatively lower than in other countries in the
Middle East and other regions of the
world [4]. However, the number of
ESRD patients on hemodialysis rose from
666 in 2011 to 1014 in 2015 [5].
In end-stage renal disease patients
undergoing hemodialysis, multiple ocular
anomalies may occur because of their
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uremic condition and dialysis procedure
[6, 7]. These abnormalities include the
decreased density of corneal endothelium
cells, refractive changes, conjunctival
calcium deposits, ischemic optic neuropathy, symptoms and signs of ocular surface disease, and intraocular pressure
(IOP) changes. Several metabolic parameters, including sodium, potassium, glucose, and blood urea, can fluctuate during
hemodialysis. Osmotic changes in the
blood, aqueous and vitreous humor, and
other extracellular fluids occur from these
fluctuations. This puts the patient at a
high risk of ocular complications such as
IOP changes, band keratopathy, conjunctival, corneal calcium deposits, exudative
retinal detachment, and cataract [8].
Increased IOP is a well-known risk
factor for glaucoma development and
progression [9, 10], as are IOP fluctuations [11]. Various techniques (Goldmann, Perkins, Schiotz, pneumotonometer, air tonometer) measure intraocular
pressure. Goldmann applanation tonometry technology is already considered the
gold standard in the evaluation of IOPs
[12].
The relationship between chronic
hemodialysis and IOP has been thoroughly studied in the past. However, the findings of studies previously published tend
to be inconsistent [13–15]. This can be
attributed to methodological differences,
such as different exclusion requirements,
other tonometry techniques, and variable
sample size. These are likely due to significant technological advancements in
the hemodialysis process over the years
[16]. Several studies show an increase in
IOP during hemodialysis sessions. Other
studies have shown the contrary effect,
while some studies did not show IOP
change during hemodialysis.
Identifying
susceptible to
fluctuations in
identify patients

patient-related factors
significant intra-ocular
hemodialysis can help
at high risk of visual ef-

fects in the earliest steps. It can help
avoid any related visual impacts or disabilities by detecting them.
The purpose of this study was, therefore, to test IOP changes after hemodialysis sessions. The aim is to show the possible correlation between IOP change and
baseline systolic blood pressure (SBP),
diastolic blood pressure (DBP), body
weight, and other laboratory parameters.
METHODS
Study Design and population
This prospective observational correlation study of 60 patients (120 eyes)
with ESRD was carried out at a major
tertiary teaching hospital dialysis Unit in
Palestine between January and March
2017. This unit is the largest dialysis center in the region, with more than 350 patients receiving hemodialysis and peritoneal dialysis therapy.
All patients were on regular hemodialysis (three times weekly, 4 hours per
session) from both genders. We excluded
patients with an ocular disorder that may
interfere with retinal and intraocular pressure measurements, such as active infection, prior eye surgery, or any irregular
corneal opacity and glaucoma.
The study was carried out with the
Institutional Review Board (IRB) approval of the An-Najah National University. After receiving oral and written information on the study's intent and the
potential implications for clinical practice, all patients gave informed oral and
written consent to participate in the study.
Measurements
We conducted eye examinations, including Snellen visual acuity, Slit-lamp
fundoscopy (Haag-Streit BM 900), and
Goldman tonometry applanation (HaagStreit, AT 900), on both eyes after taking
clinical history. IOP measurements were
taken within 30 minutes before and after
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hemodialysis. Ultrafiltration during dialysis was recorded. Pre-and posthemodialysis blood samples for osmolarity analysis were obtained.
Demographic and clinical information were derived from medical records (age, gender, and hemodialysis period in years and diabetic status) using a
data abstraction sheet. Factors affected by
hemodialysis include systolic and diastolic and diastolic blood pressure, body
weight, hemoglobin, hematocrit, serum
sodium, serum potassium, serum chloride, glucose level, Blood Urea Nitrogen
(BUN), and albumin, were assessed twice
before and after hemodialysis.
The IOP of the patient sitting upright
at the slit-lamp microscope was measured
(average of two readings) using the same
calibrated Goldman applanation tonometer for the entire study duration. One investigator (YS) conducted all the measurements to remove the intra-observer
bias. Measures of IOP intradialytic have
not been reported. Many studies have
shown that IOP changes follow a linear
pattern with maximum changes occurring
at the end of hemodialysis [17, 18].
Statistical Analysis

Statistical Package for Social Sciences (SPSS) was used to analyze data. The
mean ± SD of each parameter for the
whole group was calculated. These values were also separately determined in
different groups. The data were explored
for normality and found to derive from a
normal distribution. The paired sample ttest determined the significance of the
change in IOP after Hemodialysis. We
used an independent t-test to assess IOP
change concerning age, sex, and diabetes
status. The Pearson coefficient test was
used to determine the correlation between
IOP change and baseline serum albumin
levels, sodium levels, SBP, DBP, weight,
potassium, chloride, BUN, and osmolarity. We set the significance level at <0.05.
RESULTS
Sixty patients (120 eyes) participated
in this study. The mean age was 55.5 ±
12.6 years. Thirty-two of the patients
were males (53.3%), and 22 (36.7%), 14
males and eight females, were diabetic.
Their mean duration of hemodialysis was
3.9 ± 3.4 years. The participants' average
body weight was 77.9 ± 15.4 kg, and
their mean SBP was 135 ± 19.5 (Table
1).

Table (1): Background and clinical characteristics of the participants (n=60).
Characteristic
Age (years)
< 60 years
≥ 60 years
Sex
Male
Female
Diabetes status
Yes
No
Duration on hemodialysis (years)
SBP* (mmHg)
Bodyweight* (kg)

Number (%)

Mean ± SD
55.5±12.6

34 (56.7%)
26 (43.3%)
32(53.3%)
28(46.7%)
22 (36.7%)
36 (63.3%)
3.9±3.4
135±19.5
77.9 ±15.4

*Before dialysis, SBP: systolic blood pressure
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Comparing IOP before and after hemodialysis, it was noted that it decreased
significantly by 1.89 mmHg (P<0.001).
While the IOP decreased, its value remained within the normal range (11-21
mmHg). The SBP and DBP significantly
decreased
by
10.01mmHg
and
8.40mmHg (P<0.001). The body weight
reduced considerably (P<0.001) after
hemodialysis by 2.94Kg and blood glucose and sodium levels increased signifi-

cantly by 14.3 mg/dL (P=0.004) and 4.7
mmol/L (P<0.001) respectively. On the
other hand, serum potassium and BUN
levels significantly decreased after the
hemodialysis session by 1.3mol/L and
32.2mg/dL, respectively (P<0.001), and
the albumin levels increased considerably
by 0.56g/dL (P<0.001). Serum osmolarity and chloride didn't show significant
change after the hemodialysis session
(P=<0.05).

Table (2): Effect of hemodialysis on IOP and systematic parameters.
Before Hemodialysis
IOP, mmHg
14.28±2.676
SBP, mmHg
135.4±19.6
DBP, mmHg
78.9±15.4
Body Weight,kg
77.9±15.4
Glucose, mg/dL
127.8±59.2
Sodium, mmol/L 139.5±3.5
Potassium, mol/L 4.89±0.89
BUN, mg/dL
53.9±16.9
Albumin, g/dL
4.1±2.2
Chloride, mmol/L 98.3±4.18
Osmolarity,
305.3±9.1
mOsm
Variables

After Hemodialysis
12.4±2.3
125.4±22.8
70.5±14.014
75.0±15.3
142.1±49.
144.2±2.3
3.6±0.42
21.7±9.3
4.7±2.5
98.6±3.49

Mean difference
(95% CI)
1.89(-2.41--1.37)
10.1 (-13.8 --6.6)
8.40 (-11.3- -5.4)
2.94 (-3.1 - -2.8)
14.3 (0.48-23.8)
4.70 (4.2 - 5.2)
1.29(-1.43--1.15)
32.2(-34.2--30.2)
0.56 (0.47-067)
0.25 (-0.32-0.81)

%
change
13.2%
08.0%
10.7%
03.8%
11.2%
03.4%
26.4%
59.7%
13.7%
01.0%

Pvalue*
<0.001
<0.001
<0.001
<0.001
0.004
<0.001
<0.001
<.001
<0.001
0.391

304.0±4.4

-

0.04%

0.062

1.3 (-2.7- 0.07)

CI: confidence interval, IOP: intraocular pressure, SBP: systolic blood pressure, DBP: diastolic
blood pressure, BUN: blood urea nitrogen

The correlation between the changes in the IOP and the different measured variables
was investigated. No significant difference in IOP between patients ≥60 years of age and
patients under 60 years of age. On the other hand, IOP change was more marked among
females (P<0.001) and patients with diabetes (P=0.001) (Table 3).
Table (3): Intraocular pressure change with gender and sex.
Characteristic
Age
< 60 years
≥ 60 years
Sex
Male
Female
Diabetes status
Yes
No
* Independent t-test

IOPMean (±SD)

P-value*

-2.3 (±2.8)
-1.4 (±2.9)

0.103

-1.0 (±2.8)
-2.9 (±2.7)

<0.001

-3.0 (±2.4)
-1.3 (±2.9)

0.001
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The analysis was conducted to assess
if hemodialysis-induced IOP changes
were correlated with baseline serum albumin levels, sodium levels, SBP, DBP,
weight, potassium, chloride, BUN, and
osmolarity. Spearman's correlation found
that changes in IOP were significantly
correlated with baseline in SBP
(P=0.002) serum sodium (P<0.001), chloride (P=0.034), BUN (P=0.01), and osmolarity (P<0.001) (Tables 4).

The body weight substantially decreased
by around 3 kg, reflecting the dialysisremoving fluid that lowers systolic and
diastolic blood pressure. The increase in
serum sodium levels is due to the dilution
effect of excess water in the body before
dialysis and the high sodium concentration in the dialysis system. BUN dropped
considerably because urea is removed
from the body during dialysis. Serum
osmolarity has not changed significantly.

Table (4): Correlation between changes
in the IOP and other variables.

Correlation between IOP change and
other baseline variables revealed that serum osmolality, serum sodium, serum
chloride, and SBP significantly correlated
with the IOP change.

Variables
Bodyweight, Kg
SBP, mmHg
DBP, mmHg
Serum Sodium,
mmol/L
Potassium,mmol/L
Chloride, mmol/L
BUN, mg/dL
Glucose, mg/dL
Albumin, g/dL
Osmolarity, mOsm

IOP change
Pr
value*
0.117
0.203
0.274
0.002
0.131
0.152
-0.351

<0.001

-0.070
-0.193
-0.235
-0.086
-0.044
-0.394

0.450
0.034
0.01
0.353
0.635
<0.001

* Spearman's test, IOP: intraocular pressure,
SBP: systolic blood pressure, DBP: diastolic
blood pressure, BUN: blood urea nitrogen

DISCUSSION
from end-stage renal disease (ESRD),
Intra-ocular pressure is the eye's fluid
pressure created by the equilibrium between aqueous humor production and
drainage [19]. The study's objective was
to examine the impact of hemodialysis on
IOP in ESRD patients and address its related risk factors. The study showed a
significant decrease in IOP after hemodialysis in 78% of the patients with a mean
change of -1.89 mmHg.
The change that occurs in variables
after hemodialysis has been expected.

Our study's results are supported by
findings of other studies, which reported
that IOP significantly decreases after the
hemodialysis session [13, 20, 21]. Further
studies showed the opposite results and
claimed that hemodialysis would raise
IOP values [22]. Samsudin et al. investigated the impact of hemodialysis on IOP
and did not find significant change [14].
Nowadays, improved renal dialysis techniques such as high-flux hemodialysis
maintain better osmolar balance and prevent a marked IOP elevation. Another
explanation that illustrates the IOP decrease is attributed to the change in the
SBP, which is significantly correlated
with the IOP [23]. Thus, more decline in
the SBP will cause the IOP to decrease
more.
Fluid removal during the hemodialysis process allows water to be transferred
from plasma to the dialysate, leaving behind large proteins such as albumin and
globulin as they cannot cross the membrane. As a result, plasma protein concentration increases, and a colloid gradient between plasma and interstitial fluid
is formed, so water transfers through capillary endothelia from interstitial and
aqueous humor to plasma fluid IOP decreases [24].
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Significant associations have been
observed in other studies between serum
osmolarity and IOP changes during hemodialysis. These studies indicated that
ocular fluid difference and plasma osmolarity might cause the IOP to change [16,
25]. In patients with obstructed aqueous
outflow, this increased IOP is even more
pronounced [26].
This study has some limitations that
should be taken into consideration when
interpreting its results. The fact that the
sample was conveniently selected and
included a relatively small sample size
and that a single ophthalmologist was
performing the patient assessment could
limit its generalizability. The anterior
chamber, which would have given some
outflow facility results, was not evaluated; patients described as having obstructed outflow pathways may have had findings that differed from those of other patients during hemodialysis. Another limitation of the current research is not measuring plasma colloid osmotic pressure,
probably the primary mechanism responsible for decreasing IOP. The lack of central corneal thickness assessment is another limitation of the current research, as
measured IOPs have been shown to differ
based on central corneal thickness. IOP is
not a constant value but varies considerably due to a number of factors working
over periods ranging from seconds to
minutes or hours; some are acting over
more extended periods [27]. Regular IOP
variations are expected, and countervailing measures are in place to protect the
tissues' integrity. However, in the case of
abnormal IOP elevations, or where normal counterbalancing mechanisms are
defective, damage may be more likely to
occur [27].
Conclusions and Recommendations
In conclusion, we observed that hemodialysis treatment affects IOP and
several other laboratory parameters significantly. Hemodialysis likely causes

underestimation of IOP and corneal morphometry changes, and these changes
may be necessary when planning corneal
or lenticular surgeries in hemodialysis
patients.
Findings from this study showed that
while total blood osmolarity decreased
after hemodialysis when this change is
smaller, osmolarity is still higher and
more fluid is transferred to blood with a
higher drop in IOP compared to a more
significant change. This indicates that
osmolarity decreased by higher values,
and thus less fluid would transit to blood,
leaving IOP at a high level.
Even though hemodialysis decreases
the IOP, which reduces the risk of optic
nerve damage, it's recommended to follow up with all patients for a routine ophthalmic checkup, especially those patients
with DM who is already risky for retinopathy.
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